Patents by Inventor Andre Ulmann

Andre Ulmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8722653
    Abstract: The invention relates to a method for treating uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17?-acetoxy-11?-[4-N,N-dimethylamino-phenyl)-19-norpregna-4,9-diene-3,20-dione (ulipristal) or any metabolite thereof. More particularly, the method is useful for reducing or stopping bleeding in a patient afflicted with uterine fibroids, and/or for reducing the size of uterine fibroids.
    Type: Grant
    Filed: September 19, 2012
    Date of Patent: May 13, 2014
    Assignees: Laboratoire HRA-Pharma, The United States of America, as Represented by the Secretary, Department of Health and Human Services
    Inventors: Lynnette Nieman, Andre Ulmann, Diana Blithe, Erin Gainer
  • Patent number: 8652543
    Abstract: Compositions are disclosed containing, as active ingredients, an extract of Allium species, an extract of Citrus species and either an extract of Paullinia species and an extract of Theobroma species, or an extract of Salix species and zinc sulphate, and the method of preparation of these compositions, and cosmetic and/or pharmaceutical application of these compositions.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: February 18, 2014
    Assignee: Legacy Healthcare Holding Ltd.
    Inventors: André Ulmann, Jean-Frédéric Laville
  • Publication number: 20130210788
    Abstract: The invention provides a method for providing post coital contraception in a female subject, comprising providing the subject with a therapeutically effective amount of ulipristal acetate, wherein the female subject is overweight or obese.
    Type: Application
    Filed: December 1, 2010
    Publication date: August 15, 2013
    Applicant: LABORATOIRE HRA-PHARMA
    Inventors: Delphine Levy, Andre Ulmann, Henri Camille Mathe, Erin Gainer
  • Publication number: 20130090318
    Abstract: The invention provides a method for providing contraception in a woman, wherein the woman is administered with a progestogen-only contraception composition once-a-month between the 1st and the 10th day of the woman menstrual cycle. It is further provided a system for reminding a woman of taking such contraceptive composition.
    Type: Application
    Filed: June 24, 2011
    Publication date: April 11, 2013
    Applicant: LABORATOIRE HRA-PHARMA
    Inventors: Andre Ulmann, Erin Gainer, Delphine Levy
  • Publication number: 20130045959
    Abstract: The invention provides a method for providing post coital contraception in a female subject, comprising providing the subject with a therapeutically effective amount of ulipristal acetate, between about 3 to about 5 days after unprotected intercourse.
    Type: Application
    Filed: December 3, 2010
    Publication date: February 21, 2013
    Inventors: Andre Ulmann, Henri Camille Mathe, Erin Gainer, Diana Blithe
  • Patent number: 8361522
    Abstract: Compositions are disclosed containing, as active ingredients, an extract of Allium species, an extract of Citrus species and either an extract of Paullinia species and an extract of Theobroma species, or an extract of Salix species and zinc sulphate, and the method of preparation of these compositions, and cosmetic and/or pharmaceutical application of these compositions.
    Type: Grant
    Filed: February 8, 2008
    Date of Patent: January 29, 2013
    Assignee: Legacy Healthcare Holding Ltd
    Inventors: André Ulmann, Jean-Frédéric Sturer
  • Patent number: 8299050
    Abstract: The invention relates to a method for treating uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17?-acetoxy-11?-[4-N,N-dimethylamino-phenyl)-19-norpregna-4,9-diene-3,20-dione (ulipristal acetate) or any metabolite thereof. More particularly, the method is useful for reducing or stopping bleeding in a patient afflicted with uterine fibroids, and/or for reducing the size of uterine fibroids.
    Type: Grant
    Filed: January 29, 2008
    Date of Patent: October 30, 2012
    Assignees: Laboratoire HRA-Pharma, The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Lynnette Nieman, André Ulmann, Diana Blithe, Erin Gainer
  • Publication number: 20120232043
    Abstract: The invention relates to a method for terminating pregnancy or for menstrual induction, which method comprises administering a female subject with lubiprostone, preferably in combination of a progesterone receptor antagonist, such as mifepristone.
    Type: Application
    Filed: September 15, 2010
    Publication date: September 13, 2012
    Applicant: CEMAG
    Inventor: Andre Ulmann
  • Publication number: 20120129825
    Abstract: The invention relates to a method for contraception, which method comprises on-demand administering levonorgestrel or norgestrel in a woman, within 24 hours before an intercourse.
    Type: Application
    Filed: April 13, 2010
    Publication date: May 24, 2012
    Inventors: Andre Ulmann, Erin Gainer, Elizabeth Gray Raymond
  • Publication number: 20120122828
    Abstract: The invention relates to a method for on-demand contraception, which method comprises administering a progestogen agent or progesterone receptor modulator, such as 17a-acetoxy-11b-[4-N,N-dimethylamino-phenyl)-19-norpregna-4,9-diene-3,20-dione (ulipristal acetate) in a woman, within 72 hours before an intercourse or within 120 hours after the intercourse.
    Type: Application
    Filed: April 13, 2010
    Publication date: May 17, 2012
    Applicant: LABORATOIRE HRA PHARMA
    Inventors: Andre Ulmann, Erin Gainer
  • Publication number: 20120064174
    Abstract: The present teachings provide methods for stimulating the hair growth on a human head including simultaneous administration: a) by oral or transdermal route of a composition containing a 5-alpha-reductase inhibitor or a peripheral vasodilator, and b) by topical route of a composition containing as active ingredient an extract of Allium species, an extract of Citrus species and either an extract of Paullinia species and an extract of Theobroma species or an extract of Salix species and zinc sulfate.
    Type: Application
    Filed: August 2, 2011
    Publication date: March 15, 2012
    Applicant: LEGACY HEALTHCARE HOLDING LTD.
    Inventors: Saad Harti, André Ulmann
  • Publication number: 20110245211
    Abstract: The invention relates to a method of contraception, which method comprises administering to a woman in need thereof an emergency contraception during one or two days, followed by a prolonged low dosage contraceptive treatment until next menstrual period.
    Type: Application
    Filed: December 11, 2009
    Publication date: October 6, 2011
    Inventors: Erin Gainer, André Ulmann, Luc Massart, Hélène Guillard
  • Publication number: 20100261693
    Abstract: The invention relates to a method for treating Cushing's syndrome in a patient, which method comprises administering the patient with a pharmaceutical composition comprising a glucocorticoid receptor antagonist, at least twice a day, or an extended-release composition of a glucocorticoid receptor antagonist, or a combination of a glucocorticoid receptor antagonist and a inhibitor of cortisol synthesis.
    Type: Application
    Filed: October 13, 2008
    Publication date: October 14, 2010
    Inventors: André Ulmann, Erin Gainer, François Vuillet
  • Publication number: 20100104671
    Abstract: Compositions are disclosed containing, as active ingredients, an extract of Allium species, an extract of Citrus species and either an extract of Paullinia species and an extract of Theobroma species, or an extract of Salix species and zinc sulphate, and the method of preparation of these compositions, and cosmetic and/or pharmaceutical application of these compositions.
    Type: Application
    Filed: February 8, 2008
    Publication date: April 29, 2010
    Applicant: LEGACY HEALTHCARE HOLDING LTD.
    Inventors: André Ulmann, Jean-Frédéric Sturer
  • Publication number: 20090192130
    Abstract: The invention relates to a method for treating uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17?-acetoxy-11?-[4-N,N-dimethylamino-phenyl)-19-norpregna-4,9-diene-3,20-dione (ulipristal) or any metabolite thereof. More particularly, the method is useful for reducing or stopping bleeding in a patient afflicted with uterine fibroids, and/or for reducing the size of uterine fibroids.
    Type: Application
    Filed: January 29, 2008
    Publication date: July 30, 2009
    Applicant: HRA PHARMA
    Inventors: Lynnette NIEMAN, Andre ULMANN, Diana BLITHE, Erin GAINER
  • Patent number: 5522262
    Abstract: A disposable specific gravity tester of liquids such as urine comprising a form-maintaining, flexible or resilient, transparent plastic pipet-type tube, one end of which is integrally closed to form a self-contained bulb, the other normally open end of which is fixedly closed with a solid liquid-permeable plug permitting inward passage there through of the liquid to be tested, and at least one floatable solid testing body in the tube with a predetermined specific gravity at or approximating the expected or normal specific gravity of the liquid; and its method of use, comprising squeezing the bulb while the other plugged end is below the surface of the liquid, releasing the squeezing force to suck up into the tube sufficient liquid to float the testing body or bodies, and observing if and/or which body or bodies sink, float or remain suspended in the liquid.
    Type: Grant
    Filed: March 3, 1994
    Date of Patent: June 4, 1996
    Inventors: Moh Samir Amer, Jean-Marie Brisset, Andre Ulmann, Jean P. Delage-Toriel, Jacques Stemer